Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
548.12
+3.35 (0.61%)
At close: Dec 5, 2025, 4:00 PM EST
500.00
-48.12 (-8.78%)
After-hours: Dec 5, 2025, 7:59 PM EST
Medpace Holdings Market Cap
Medpace Holdings has a market cap or net worth of $15.44 billion as of December 5, 2025. Its market cap has increased by 60.80% in one year.
Market Cap
15.44B
Enterprise Value
15.30B
1-Year Change
60.80%
Ranking
Category
Stock Price
$548.12
Market Cap Chart
Since August 11, 2016, Medpace Holdings's market cap has increased from $1.10B to $15.44B, an increase of 1,301.43%. That is a compound annual growth rate of 32.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 15.35B | 48.60% |
| Dec 31, 2024 | 10.33B | 9.79% |
| Dec 29, 2023 | 9.41B | 42.38% |
| Dec 30, 2022 | 6.61B | -15.55% |
| Dec 31, 2021 | 7.82B | 57.08% |
| Dec 31, 2020 | 4.98B | 64.41% |
| Dec 31, 2019 | 3.03B | 60.71% |
| Dec 31, 2018 | 1.88B | 38.21% |
| Dec 29, 2017 | 1.36B | -7.16% |
| Dec 30, 2016 | 1.47B | 33.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |